G2061: Fecal Calprotectin Testing in Adults
Defines coverage criteria for fecal calprotectin testing for individuals aged 18 years and older, including when testing to differentiate IBD from IBS and for monitoring response/relapse in IBD; excludes other uses. Provides background, guideline alignment, FDA device summaries, and one CPT code reference.
01/01/2025: Updated background, guidelines, and references; clarified that policy applies to adults (18+) and simplified Section III wording without changing coverage criteria.
02/01/2026: Proposed for archival; clinical information and coverage criteria moved to G2121.
02/01/2026: Proposed for Archival; clinical information and coverage criteria moved to G2121.
01/01/2025: Reviewed and Updated; clarified that policy is specific to adults (18+) and simplified coverage criteria wording; updated description for CPT 83993.
05/01/2024: Reviewed and Updated; background, guidelines and references updated without changes to coverage criteria.
03/10/2023: Updated background, guidelines and references; clarified coverage criteria language.
05/15/2022: Initial Policy Implementation
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.